Skyrizi 150 MG/ML penml
Ended Awarded
- Contract number
- SPE2DB26FKFCP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,173
Award facts
- Contract value 100% obligated
- $38,173.29 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $38,173.29 delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Skyrizi 150 mg/ml pen injectors. This is a firm fixed-price, competitively awarded contract with performance scheduled to be completed by October 27, 2025, and will be fulfilled at the company's corporate office location in Conshohocken, Pennsylvania. Skyrizi is a biologic immunosuppressant used in the treatment of autoimmune conditions, reflecting the breadth of specialty pharmaceutical products that the Defense Logistics Agency procures to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor in the federal medical supply chain, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency and supplies a comprehensive range of pharmaceutical products, medical devices, and healthcare commodities to support global military health operations. The company's performance across numerous competitively awarded contracts demonstrates its capacity to meet federal procurement requirements for diverse medical supply needs across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FKFCP?
SPE2DB26FKFCP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 24, 2025.
How much is contract SPE2DB26FKFCP worth?
The government has obligated $38,173 on SPE2DB26FKFCP.
Is contract SPE2DB26FKFCP an order under another contract?
Yes. SPE2DB26FKFCP is a delivery order under SPE2DB24D2101, an indefinite delivery contract.
Was contract SPE2DB26FKFCP competed?
The extent of competition for SPE2DB26FKFCP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award